quant Healthcare Fund - IDCW Option - Direct Plan
NAV as on 2026-07-17 · Equity · Sectoral/Thematic
AUM
₹391 Cr
1Y Return
+11.0%
3Y CAGR
-
5Y CAGR
-
Expense
1.38%
Risk
Very High
1Y Return
+11.0%
3Y CAGR
-
5Y CAGR
-
Since Inception
+21.8%
AI Fund Analysis
Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.
NAV History
Drag or scroll the chart to pan through history
52-Week NAV Range
94% from 52W low
Fund Information
Fund House
quant Mutual Fund
Category
Equity - Sectoral/Thematic
Min SIP
₹500
Min Lumpsum
₹5,000
Portfolio Composition
Asset Allocation
Market Cap Split
Top Holdings
Zydus Wellness Ltd
Consumer Defensive
Anthem Biosciences Ltd
Healthcare
Aster DM Healthcare Ltd Ordinary Shares
Healthcare
SMS Pharmaceuticals Ltd
Healthcare
Viyash Scientific Ltd
Healthcare
TREPS (Cash)
Alivus Life Sciences Ltd
Healthcare
HFCL Ltd
Technology
Pfizer Ltd
Healthcare
Aurobindo Pharma Ltd
Healthcare
Sector Allocation
Fundamentals
P/E Ratio
40.92
Cat avg: 42.00
P/B Ratio
5.08
Cat avg: 5.97
Dividend Yield
0.53%
Cat avg: 0.61%
Price/Sale
5.47
Price/Cash Flow
27.93
Peer Comparison
| Fund | AUM (Cr) | Exp % | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Quant Healthcare Dir IDCW-P | 391 | 1.38 | +11.0% | - | - |
| Nippon India Pharma Dir Bns | 9,044 | 0.79 | +7.5% | +20.8% | +13.4% |
| ICICI Pru Pharma Healthcare Dg DirIDCW-P | 6,625 | 0.86 | +6.6% | +24.9% | +16.0% |
| SBI Healthcare Opportunities Dir IDCW-P | 4,998 | 0.91 | +14.8% | +24.7% | +17.4% |
| DSP Healthcare Fund Dir IDCW-P | 3,514 | 0.51 | +10.1% | +22.8% | +15.5% |
| Mirae Asset Healthcare Dir IDCW-P | 3,253 | 0.44 | +12.5% | +23.7% | +14.6% |
| HDFC Pharma and Healthcare Dir IDCW-P | 2,611 | 1.08 | +19.3% | - | - |
| Tata India Pharma & Healthcare DirIDCW-P | 1,455 | 0.67 | +8.1% | +22.5% | +14.8% |
| UTI Healthcare Dir IDCW-P | 1,308 | 1.31 | +12.7% | +26.4% | +15.4% |
| Aditya BSL Pharma & Hlthcare Dir IDCW-P | 1,011 | 0.82 | +14.5% | +23.1% | +14.0% |
What If I Had Invested?
NAV history not available for this range
Key Metrics
Risk-o-Meter
Low
Moderate
High
Very High
Rated as Very High risk
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.